Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022

SELL
$1.09 - $2.55 $2,571 - $6,015
-2,359 Closed
0 $0
Q3 2021

Nov 09, 2021

SELL
$2.06 - $5.34 $3,909 - $10,135
-1,898 Reduced 44.59%
2,359 $6,000
Q2 2021

Aug 13, 2021

SELL
$2.88 - $5.64 $35,305 - $69,140
-12,259 Reduced 74.22%
4,257 $12,000
Q1 2021

May 13, 2021

BUY
$3.4 - $7.97 $34,479 - $80,823
10,141 Added 159.07%
16,516 $58,000
Q4 2020

Feb 11, 2021

SELL
$4.11 - $7.51 $10,673 - $19,503
-2,597 Reduced 28.95%
6,375 $31,000
Q3 2020

Nov 12, 2020

SELL
$3.28 - $5.93 $90,058 - $162,820
-27,457 Reduced 75.37%
8,972 $43,000
Q2 2020

Aug 12, 2020

BUY
$3.18 - $15.54 $115,844 - $566,106
36,429 New
36,429 $119,000
Q4 2019

Feb 10, 2020

SELL
$3.94 - $5.76 $417 - $610
-106 Closed
0 $0
Q3 2019

Nov 14, 2019

BUY
$4.84 - $7.25 $513 - $768
106 New
106 $0
Q4 2018

Feb 14, 2019

SELL
$4.95 - $10.5 $19 - $42
-4 Closed
0 $0
Q3 2018

Nov 14, 2018

BUY
$9.2 - $11.5 $36 - $46
4 New
4 $0

About CHEMBIO DIAGNOSTICS, INC.


  • Ticker CEMI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 30,224,600
  • Description
  • Chembio Diagnostics, Inc., together with its subsidiaries, develops, manufactures, and commercializes point-of-care (POC) diagnostic tests that are used to detect or diagnose diseases. The company offers tests for COVID-19, HIV and Syphilis, and Zika virus. It also develops tests for malaria, dengue, chikungunya, Chagas, ebola, leishmaniasis, la...
More about CEMI
Track This Portfolio

Track Barclays PLC Portfolio

Follow Barclays PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.